市場調査レポート

商品コード

1351137

非経口包装市場の2030年までの予測- 製品タイプ別、材料タイプ別、包装タイプ別、地域別の世界分析

Parenteral Packaging Market Forecasts to 2030 - Global Analysis By Product Type (Vials, Pre-filled Syringes, Cartridges, Bags and Other Product Types), Material Type (Glass, Plastic and Other Material Types), Packaging Type and By Geography

出版日: 2023年09月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 617,935円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 781,725円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 945,515円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,116,750円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の非経口包装市場は2023年に122億4,000万米ドルを占め、2030年には190億3,000万米ドルに達すると予測され、予測期間中のCAGRは6.5%です。

非経口包装は、医薬品やヘルスケア製品に使用される溶液のタイプであり、保存期間中や薬剤が投与されるまでの間、薬剤やその他の液体の効力や治療効果を維持できるようにするものです。死亡率の高さは、COVID-19ワクチンの需要の高まりとともに、様々な慢性疾患のために効力を失うことなく医薬品やドラッグを迅速にデリバリーする需要を煽っています。その結果、ワクチンや医薬品の需要が増加し、医薬品を汚染から守る必要性も高まっています。

USP（米国薬局方）によると、非経口包装容器に使用されるガラスには2種類あります。i型ガラスはホウケイ酸ガラスで、中性製剤に使用されます。タイプIIはソーダ石灰ガラスで、酸性・アルカリ性・中性の非経口製剤の包装に使用されます。

一人当たりヘルスケア支出の増加

非経口包装の世界市場の拡大は、世界の主要経済国における一人当たりの医療サービス消費量の増加とともに考慮されています。抗体ベースの予防接種は、一般大衆の健康を著しく改善する重要な福祉介入です。親による関心は予防接種と密接な関係があります。例えば、米国による国家ワクチン計画（NVP）や世界ワクチン行動計画（GVAP）2011-2020のような予防接種プログラムは、ポリオや肝炎のような病気を根絶するために定期的に公的機関によって提示され、非経口バンドル市場をさらに活性化させるためにそれらに依存しています。

高額な初期投資

先進パッケージング技術の研究開発・導入に必要な多額の初期投資は、業界最大の課題のひとつです。これには、特殊な包装機器や材料の設計・製造にかかる費用も含まれます。さらに、小規模の製薬会社や新興企業がこうした投資に資金を割くことができない場合、市場での競争に成功する能力が制限される可能性があります。

ドラッグデリバリー技術の近代化

非経口包装事業者は、ウェアラブル注射器、自動注射器、センサー付きスマート包装などの最先端のドラッグデリバリーシステムの開発により、製薬メーカーと協力する機会を得ています。さらに、こうした技術の進歩は、患者の快適性、アドヒアランス、コンプライアンスを向上させ、独創的なパッケージングアイデアに新たな市場を開く。

価格圧力と激しい競合

非経口包装市場では激しい競合が存在し、多くの企業が市場シェアを争っています。メーカーが製薬会社との契約をめぐって競争するため、このような激しい競争の結果として価格圧力が生じることがよくあります。その結果、企業は高い水準を維持しながら研究開発や技術革新に資源を配分することが難しくなり、結果として利益率が低下する可能性があります。

COVID-19の影響：

非経口包装市場は、COVID-19の大流行により多くの点で大きな影響を受けた。製薬会社がCOVID-19ワクチンや治療薬の開発・流通を急いだため、当初は特にワクチンや必要な医薬品の包装用品やソリューションに対する需要が増加しました。さらに、この需要の増加はサプライチェーンに圧力をかけ、一部の包装部品の短期的な不足や価格の変更につながっています。パンデミックは物流や製造の混乱も引き起こし、生産と流通を遅らせた。

予測期間中はプレフィルドシリンジセグメントが最大になる見込み

プレフィルドシリンジセグメントは、予測期間を通じて最大の市場シェアを占めると予測されます。製薬会社がプレフィルドシリンジを好む理由は、その使いやすさと投与量の正確さであり、ワクチン、インスリン、生物製剤のような様々な注射薬に適した選択肢となっています。さらに、これらの注射器にはすでに1回分の薬剤が入っているため、汚染や投与ミスの可能性が低くなります。さらに、急速に発展しているバイオテクノロジー分野での使用に適しているため、新しい生物学的療法の投与にも頻繁に使用されています。

予測期間中、CAGRが最も高くなると予想されるプラスチックセグメント

プラスチックセグメントは、有利な成長を示すと推定されます。順応性、軽量性、ガラスに比べて低い製造コストのため、ポリプロピレンや環状オレフィンポリマー（COP）などのプラスチック材料が普及しています。非経口包装では、特に経口液剤や一部の注射剤にプラスチック製のバイアルや容器が頻繁に使用されています。さらに、プレフィルドプラスチックシリンジや輸液バッグのようなプラスチック包装技術の開発は、創造的で洗練されたプラスチック包装ソリューションの例です。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予想されます。この地域の確立された製薬およびバイオテクノロジー部門がこの市場の優位性の主な原因であり、その結果、洗練されたコンプライアントなパッケージングソリューションの需要を牽引しています。さらに、北米は医薬品の安全性、患者中心の包装、ヘルスケアデリバリーシステムの革新に重点を置いているため、世界の非経口包装市場でトップの地位を固めています。

CAGRが最も高い地域：

予想される期間中、欧州は大きな成長を記録する見込みです。欧州の堅調な製薬・バイオテクノロジー業界と厳しい規制環境が、継続的な技術革新と一流の非経口包装ソリューションの採用を後押ししています。さらに、欧州市場は環境の持続可能性に強く焦点を当てていることが特徴であり、環境に優しいパッケージング製品や手順の作成と採用を促しています。先進パッケージング形式を含む非経口薬に対する需要の高まりは、欧州の高齢化と慢性疾患の有病率の増加にも起因しています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレイヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第9章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

Nipro Corporation
Catalent, Inc
Sio2 Materials Science
Schott AG
Gerresheimer AG
Baxter International Inc.
Dickinson and Company
Stevanato Group S.p.A.
Corning Inc.
UDG Healthcare plc
Becton
West Pharmaceutical Services, Inc.
UFP Technologies, Inc.
Terumo Corporation

図表

List of Tables

Table 1 Global Parenteral Packaging Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 4 Global Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 5 Global Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 6 Global Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 7 Global Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 8 Global Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 9 Global Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 10 Global Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 11 Global Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 12 Global Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 13 Global Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 14 Global Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 15 Global Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 16 Global Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 17 Global Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 18 Global Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 19 Global Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 20 Global Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 21 Global Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 22 Global Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)
Table 23 North America Parenteral Packaging Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 25 North America Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 26 North America Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 27 North America Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 28 North America Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 29 North America Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 30 North America Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 31 North America Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 32 North America Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 33 North America Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 34 North America Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 35 North America Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 36 North America Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 37 North America Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 38 North America Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 39 North America Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 40 North America Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 41 North America Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 42 North America Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 43 North America Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 44 North America Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)
Table 45 Europe Parenteral Packaging Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 47 Europe Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 48 Europe Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 49 Europe Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 50 Europe Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 51 Europe Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 52 Europe Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 53 Europe Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 54 Europe Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 55 Europe Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 56 Europe Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 57 Europe Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 58 Europe Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 59 Europe Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 60 Europe Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 61 Europe Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 62 Europe Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 63 Europe Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 64 Europe Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 65 Europe Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 66 Europe Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)
Table 67 Asia Pacific Parenteral Packaging Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 69 Asia Pacific Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 70 Asia Pacific Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 71 Asia Pacific Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 72 Asia Pacific Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 73 Asia Pacific Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 74 Asia Pacific Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 75 Asia Pacific Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 76 Asia Pacific Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 77 Asia Pacific Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 78 Asia Pacific Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 79 Asia Pacific Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 80 Asia Pacific Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 81 Asia Pacific Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 82 Asia Pacific Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 83 Asia Pacific Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 84 Asia Pacific Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 85 Asia Pacific Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 86 Asia Pacific Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 87 Asia Pacific Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 88 Asia Pacific Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)
Table 89 South America Parenteral Packaging Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 91 South America Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 92 South America Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 93 South America Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 94 South America Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 95 South America Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 96 South America Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 97 South America Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 98 South America Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 99 South America Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 100 South America Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 101 South America Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 102 South America Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 103 South America Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 104 South America Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 105 South America Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 106 South America Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 107 South America Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 108 South America Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 109 South America Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 110 South America Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)
Table 111 Middle East & Africa Parenteral Packaging Market Outlook, By Country (2021-2030) ($MN)
Table 112 Middle East & Africa Parenteral Packaging Market Outlook, By Product Type (2021-2030) ($MN)
Table 113 Middle East & Africa Parenteral Packaging Market Outlook, By Vials (2021-2030) ($MN)
Table 114 Middle East & Africa Parenteral Packaging Market Outlook, By Pre-filled Syringes (2021-2030) ($MN)
Table 115 Middle East & Africa Parenteral Packaging Market Outlook, By Cartridges (2021-2030) ($MN)
Table 116 Middle East & Africa Parenteral Packaging Market Outlook, By Bags (2021-2030) ($MN)
Table 117 Middle East & Africa Parenteral Packaging Market Outlook, By Ampoules (2021-2030) ($MN)
Table 118 Middle East & Africa Parenteral Packaging Market Outlook, By Ready to Use Systems (2021-2030) ($MN)
Table 119 Middle East & Africa Parenteral Packaging Market Outlook, By Infusion solutions bottles (2021-2030) ($MN)
Table 120 Middle East & Africa Parenteral Packaging Market Outlook, By Infusion solutions bags (2021-2030) ($MN)
Table 121 Middle East & Africa Parenteral Packaging Market Outlook, By Containers (2021-2030) ($MN)
Table 122 Middle East & Africa Parenteral Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
Table 123 Middle East & Africa Parenteral Packaging Market Outlook, By Material Type (2021-2030) ($MN)
Table 124 Middle East & Africa Parenteral Packaging Market Outlook, By Glass (2021-2030) ($MN)
Table 125 Middle East & Africa Parenteral Packaging Market Outlook, By Plastic (2021-2030) ($MN)
Table 126 Middle East & Africa Parenteral Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
Table 127 Middle East & Africa Parenteral Packaging Market Outlook, By Polyolefin (2021-2030) ($MN)
Table 128 Middle East & Africa Parenteral Packaging Market Outlook, By Other Material Types (2021-2030) ($MN)
Table 129 Middle East & Africa Parenteral Packaging Market Outlook, By Packaging Type (2021-2030) ($MN)
Table 130 Middle East & Africa Parenteral Packaging Market Outlook, By Small Volume Parenteral (SVP) (2021-2030) ($MN)
Table 131 Middle East & Africa Parenteral Packaging Market Outlook, By Large Volume Parenteral (LVP) (2021-2030) ($MN)
Table 132 Middle East & Africa Parenteral Packaging Market Outlook, By Other Packaging Types (2021-2030) ($MN)

Product Code: SMRC23824

According to Stratistics MRC, the Global Parenteral Packaging Market is accounted for $12.24 billion in 2023 and is expected to reach $19.03 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Parenteral packaging is a type of solution used in pharmaceuticals and healthcare products that enables the medication or other fluid to maintain its potency and therapeutic effectiveness throughout the shelf life or until the drug is administered. The high mortality rate has fueled the demand for quick delivery of medications and drugs without loss of potency because of various chronic diseases, along with the rising demand for COVID-19 vaccines. The result has been a rise in demand for vaccines and medications, as well as the requirement to safeguard drugs from contamination.

According to USP (United States Pharmacopeia) there are two types of glass used for parenteral packaging containers. Type I glass is a borosilicate glass and used for neutral preparation. Type II is soda lime glass and is used for packaging acidic alkaline and neutral parenteral preparations.

Market Dynamics:

Driver:

Increasing per capita healthcare expenditure

The expansion of the global market for parenteral packaging is taken into account with the rising per capita consumption of medical services in the world's major economies. Antibody-based vaccinations are a significant well-being intervention that significantly improves the health of the general populace. Parenterally administered interest is closely related to immunization. For instance, vaccination programs like the National Vaccine Plan (NVP) by the U.S. and the Global Vaccine Action Plan (GVAP) 2011-2020, which are presented by the public authority at regular intervals to eradicate diseases like polio and hepatitis, are relying on them to further fuel the parenteral bundling market.

Restraint:

Expensive initial investment

The sizeable initial investment needed for research, development, and implementation of advanced packaging technologies is one of the industry's biggest challenges. Included in this are the expenses incurred in the design and production of specialized packaging equipment and materials. Moreover, the inability of smaller pharmaceutical firms and startups to allocate funds for these investments may limit their ability to successfully compete in the market.

Opportunity:

Modernized drug delivery technologies

Parenteral packaging businesses have opportunities to work with pharmaceutical manufacturers as a result of the development of cutting-edge drug delivery systems like wearable injectors, auto-injectors, and smart packaging with sensors. Furthermore, these advancements in technology increase patient comfort, adherence, and compliance, opening up new markets for creative packaging ideas.

Threat:

Price pressure and fierce competition

Intense competition is present in the parenteral packaging market, where many businesses are vying for market share. Price pressure is frequently a result of this fierce competition as manufacturers compete for contracts with pharmaceutical firms. As a result, companies may find it difficult to allocate resources for R&D and innovation while maintaining high standards, and as a result, profit margins may decrease.

COVID-19 Impact:

The parenteral packaging market was significantly impacted by the COVID-19 pandemic in numerous ways. As pharmaceutical companies raced to develop and distribute COVID-19 vaccines and treatments, it initially resulted in increased demand for packaging supplies and solutions, particularly for vaccines and necessary medications. Moreover, this increase in demand put pressure on the supply chain, leading to brief shortages and changes in price for some packaging parts. The pandemic also caused logistical and manufacturing disruptions, which delayed production and distribution.

The Pre-filled Syringes segment is expected to be the largest during the forecast period

The pre-filled syringes segment is predicted to hold the largest market share throughout the forecast period. Pharmaceutical companies prefer pre-filled syringes because of how easy they are to use and how precisely they deliver dosages, which makes them a good option for a variety of injectable medicines like vaccines, insulin, and biologics. Moreover, these syringes already contain one dose of the medication, lowering the possibility of contamination and dosage mistakes. Additionally, they are also frequently used in the administration of novel biologic therapies because they are well suited for use in the rapidly developing field of biotechnology.

The plastic segment is expected to have the highest CAGR during the forecast period

The plastic segment is estimated to witness lucrative growth. Due to their adaptability, light weight, and lower production costs compared to glass, plastic materials, such as polypropylene and cyclic olefin polymers (COP), have become more popular. Parenteral packaging frequently uses plastic vials and containers, particularly for oral liquids and some injectable drug formulations. Additionally, developments in plastic packaging technology, like pre-filled plastic syringes and infusion bags, are examples of creative and sophisticated plastic packaging solutions.

Region with largest share:

North America is expected to witness the largest market share during the forecast period. The established pharmaceutical and biotechnology sectors in this area are largely responsible for the dominance of this market, which in turn drives demand for sophisticated and compliant packaging solutions. Additionally, its position as the top region in the global parenteral packaging market is cemented by North America's emphasis on drug safety, patient-centric packaging, and innovations in healthcare delivery systems.

Region with highest CAGR:

Over the anticipated period, Europe is expected to register significant growth. The robust pharmaceutical and biotechnology industries in Europe, as well as its strict regulatory environment, encourage ongoing innovation and the adoption of top-notch parenteral packaging solutions. Moreover, the European market is distinguished by a strong focus on environmental sustainability, which has prompted the creation and adoption of eco-friendly packaging products and procedures. A growing demand for parenteral medications, including those in advanced packaging formats, has also been caused by Europe's aging population and an increase in the prevalence of chronic diseases.

Key players in the market:

Some of the key players in Parenteral Packaging market include: Nipro Corporation, Catalent, Inc, Sio2 Materials Science, Schott AG, Gerresheimer AG , Baxter International Inc., Dickinson and Company, Stevanato Group S.p.A., Corning Inc., UDG Healthcare plc, Becton, West Pharmaceutical Services, Inc. , UFP Technologies, Inc. and Terumo Corporation.

Key Developments:

In June 30, 2021, SCHOTT AG announces the inauguration of its new tube factory in Jinyun, China. The new facility will help increase production for a pharmaceutical glass tubing company used to store and package life-saving medicines.

In May 19, 2020, Sharp, a subsidiary of UDG Healthcare plc, announced that it has acquired a 160,000-square-foot pharmaceutical packaging facility from Quality Packaging Specialists International, LLC, located in Macunji, Pennsylvania, USA.

Product Types Covered:

Vials
Pre-filled Syringes
Cartridges
Bags
Ampoules
Ready to Use Systems
Infusion solutions bottles
Infusion solutions bags
Containers
Other Product Types

Material Types Covered:

Glass
Plastic
Other Material Types

Packaging Types Covered:

Small Volume Parenteral (SVP)
Large Volume Parenteral (LVP)
Other Packaging Types

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Parenteral Packaging Market, By Product Type

5.1 Introduction
5.2 Vials
5.3 Pre-filled Syringes
5.4 Cartridges
5.5 Bags
5.6 Ampoules
5.7 Ready to Use Systems
5.8 Infusion solutions bottles
5.9 Infusion solutions bags
5.10 Containers
5.11 Other Product Types

6 Global Parenteral Packaging Market, By Material Type

6.1 Introduction
6.2 Glass
6.3 Plastic
- 6.3.1 Polyvinyl Chloride (PVC)
- 6.3.2 Polyolefin
6.4 Other Material Types

7 Global Parenteral Packaging Market, By Packaging Type

7.1 Introduction
7.2 Small Volume Parenteral (SVP)
7.3 Large Volume Parenteral (LVP)
7.4 Other Packaging Types

8 Global Parenteral Packaging Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 Nipro Corporation
10.2 Catalent, Inc
10.3 Sio2 Materials Science
10.4 Schott AG
10.5 Gerresheimer AG
10.6 Baxter International Inc.
10.7 Dickinson and Company
10.8 Stevanato Group S.p.A.
10.9 Corning Inc.
10.10 UDG Healthcare plc
10.11 Becton
10.12 West Pharmaceutical Services, Inc.
10.13 UFP Technologies, Inc.
10.14 Terumo Corporation